India is expecting a rapid decline in the number of patents claim over its traditional medicinal formulations at the US and UK patents office following TKDL (Traditional Knowledge Digital Library) Access Agreements with these two countries.

A GROUP of Indian pharmaceutical firms will collectively oppose as many as 90 drug patent applications sought by global drugmakers and some local companies, terming them as frivolous patent claims.

INDIA

GLENMARK Pharmaceuticals said on Monday its unit entered an outof-court settlement with Glaxo-SmithKline LLC over patent actions on doses of atovaquone and proguanil hydrochloride, the generic version of GSK

CIPLA has launched a copycat version of German pharma company Bayer AG

K P Prabhakaran Nair

Monsanto devotes an annual budget of $10 million to harassing, intimidating, suing -and in some cases bankrupting -American farmers over alleged improper use of its patented seeds. This will become the norm for India as well

Civil Society Groups Urge End To India Project, Allege Nexus With MNC Pharma Companies

TK ARUN

GERMAN drugmaker Bayer has filed a patent infringement case against Cipla, the largest domestic drugseller, to stop the Mumbaibased company from selling its generic version of Bayer

THE Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India